Brief: Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall Of Phenytoin Oral Suspension USP, 125 Mg/5 Ml

Taro Pharmaceutical Industries

20/02/2020 23:00

Feb 20 (Reuters) - Taro Pharmaceutical Industries Ltd
 TARO.N :
    * TARO PHARMACEUTICALS U.S.A. ISSUES VOLUNTARY NATIONWIDE
RECALL
OF PHENYTOIN ORAL SUSPENSION USP, 125 MG/5 ML DUE TO POSSIBLE
UNDERDOSING OR OVERDOSING
    * TARO PHARMACEUTICALS U.S.A -  RECALLED LOTS OF PHENYTOIN
ORAL
SUSPENSION MAY NOT RE-SUSPEND WHEN SHAKEN, WHICH COULD RESULT IN
UNDER OR OVERDOSING
    * TARO PHARMACEUTICALS U.S.A -  RECALL IS BEING CONDUCTED
WITH
KNOWLEDGE OF FDA

Source text for Eikon:  ID:nBw29XJXsa 
Further company coverage:  TARO.N 

 ((Reuters.Briefs@thomsonreuters.com;))